We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$8.02B
AUM Growth
+$201M
Cap. Flow
-$89M
Cap. Flow %
-1.11%
Top 10 Hldgs %
19.81%
Holding
867
New
76
Increased
308
Reduced
302
Closed
63

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$48.8M
2
PG icon
Procter & Gamble
PG
+$24.6M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$23.6M
4
KEYS icon
Keysight
KEYS
+$23.2M
5
BMY icon
Bristol-Myers Squibb
BMY
+$21.2M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$46.5M
2
XOM icon
ExxonMobil
XOM
+$36.6M
3
GG
Goldcorp Inc
GG
+$24.9M
4
DIS icon
Walt Disney
DIS
+$23.8M
5
NAVG
Navigators Group Inc
NAVG
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 33.16%
2 Technology 16.87%
3 Financials 10.38%
4 Consumer Discretionary 9.09%
5 Communication Services 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LTM
776
DELISTED
LATAM Airlines Group S.A American Depositary Shares (Each representing 1 Common Share)
LTM
$157K ﹤0.01%
16,880
– –
OVV icon
777
Ovintiv
OVV
$17.5B
$135K ﹤0.01%
5,284
-44,921
-89% -$1.4M
GFI icon
778
Gold Fields
GFI
$29.2B
$114K ﹤0.01%
21,122
-1,000
-5% -$4.27K
APHA
779
DELISTED
Aphria Inc. Common Shares
APHA
$77K ﹤0.01%
11,000
– –
BLDP
780
Ballard Power Systems
BLDP
$874M
$45K ﹤0.01%
11,000
– –
FBIO icon
781
Fortress Biotech
FBIO
$111M
$34K ﹤0.01%
+1,500
New +$38.6K
TTPH
782
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$7K ﹤0.01%
781
– –
ABUS icon
783
Arbutus Biopharma
ABUS
$865M
– –
-105,000
Closed -$376K
AGNC icon
784
AGNC Investment
AGNC
$12.3B
– –
-52,086
Closed -$938K
ANDE icon
785
Andersons Inc
ANDE
$2.65B
– –
-14,000
Closed -$451K
AZUL
786
DELISTED
Azul
AZUL
– –
-344,000
Closed -$10M
CAE icon
787
CAE Inc. Common Shares
CAE
$8.1B
– –
-17,724
Closed -$393K
CHDN icon
788
Churchill Downs
CHDN
$6.03B
– –
-9,000
Closed -$406K
CRUS icon
789
Cirrus Logic
CRUS
$6.74B
– –
-13,000
Closed -$547K
CSL icon
790
Carlisle Companies
CSL
$13.6B
– –
-4,000
Closed -$491K
D icon
791
Dominion Energy
D
$62.5B
– –
-73,601
Closed -$5.64M
DDS icon
792
Dillards
DDS
$8.87B
– –
-6,000
Closed -$432K
EAT icon
793
Brinker International
EAT
$8.02B
– –
-10,000
Closed -$444K
FDS icon
794
Factset
FDS
$9.05B
– –
-2,000
Closed -$497K
GOOD
795
Gladstone Commercial Corp
GOOD
$627M
– –
-10,020
Closed -$208K
HELE icon
796
Helen of Troy
HELE
$663M
– –
-4,000
Closed -$464K
IMO icon
797
Imperial Oil
IMO
$62.1B
– –
-19,837
Closed -$542K
INGR icon
798
Ingredion
INGR
$6.38B
– –
-4,310
Closed -$408K
IT icon
799
Gartner
IT
$9.41B
– –
-19,229
Closed -$2.92M
JBHT icon
800
JB Hunt Transport Services
JBHT
$27.1B
– –
-4,506
Closed -$456K
30 31
32
33 34

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2019 Portfolio in Review

As of Q2 2019, Candriam SCA held 867 positions worth $8.02B, up 2.6% from $7.82B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q2 2019 filing shows 76 new, 308 increased, 302 reduced and 63 closed positions. Its largest new stake was Total System Services, Inc.: 112,342 shares worth $14.3M. The largest sale was Celgene Corp, an estimated $46.5M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2019 buy was Total System Services, Inc.: 112,342 shares worth $14.3M.
  • Candriam SCA added most to Vertex Pharmaceuticals in Q2 2019, an estimated $48.8M increase.
  • Candriam SCA's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $46.5M.
  • Candriam SCA fully exited Goldcorp Inc in Q2 2019, selling an estimated $24.9M.
  • Candriam SCA's ten largest holdings make up 20% of its $8.02B portfolio in Q2 2019.
  • Candriam SCA opened 76 new positions and closed 63 in Q2 2019.
  • Candriam SCA's portfolio value rose 2.6% quarter-over-quarter to $8.02B.

Based on Candriam SCA's 13F filing for Q2 2019, filed 1 Aug 2019.